Redona Therapeutics

United States
Glenview, Illinois, United States

Company profile

Redona Therapeutics company profile

Redona Therapeutics specializes in the modulation of functional non-coding RNA to treat cancer and other human diseases. By targeting ncRNA modulating proteins (RMPs), they use small molecules to modulate expression levels of oncogenes and other proteins of significance in disease.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Founded
2016-01-01, Year

Headquarters

Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
3
Total equity funding
$60.8M
Last funding
Series Unknown / $60.8M / 2023-07-31
Last equity funding
Series Unknown / $60.8M
Investors
1
Founders
4
Articles
4

Founders and investors

Founders

Frank SlackGeorge DaleyPiotr SlizRichard Gregory

Investors

Astellas Venture Management